deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT03531294

Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement

Sponsor: Greater Houston Retina Research

Conditions Diabetic Retinopathy
Interventions Aflibercept Injection
Updated 8 times since 2018 Last updated: May 19, 2021 Started: May 23, 2018 Primary completion: Apr 9, 2021 Completion: Apr 9, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Diabetic Retinopathy and is currently completed. Greater Houston Retina Research leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotNot Yet Recruiting~Aug 2018 – ~Mar 2020 · 19 months · monthly snapshotRecruiting~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotActive Not Recruiting~Apr 2021 – ~Jun 2021 · 2 months · monthly snapshotActive Not Recruiting~Jun 2021 – ~Jul 2024 · 37 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jun 2021 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Apr 2021 — Jun 2021 [monthly]

    Active Not Recruiting PHASE2

  5. Jan 2021 — Apr 2021 [monthly]

    Active Not Recruiting PHASE2

▶ Show 3 earlier versions

  1. Mar 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Aug 2018 — Mar 2020 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  3. Jun 2018 — Aug 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Greater Houston Retina Research
  • Regeneron Pharmaceuticals
  • The Cleveland Clinic
Data source: Greater Houston Retina Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations